Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology
Business Model:
Revenue: $0
Employees: 1-10
Address: 3 Golda Meir
City: Ness-Ziona
State: tel aviv district
Zip: 74100
Country: IL
Innoventric is a Structural Heart medical device company, mainly engaged in the development of percutaneous solutions for Tricuspid Regurgitation and right heart disease. Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium™ technology for the treatment of Tricuspid Valve Regurgitation. The company was founded in 2017, and has rapidly progressed. Innoventric has performed over 10 implantations of the promising Trillium™ technology as part of its European first in human clinical trial. The company holds a broad patent portfolio for the Trillium™ and additional Tricuspid technologies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2021 | Series A | $11.1M |
Horizon Europe |
11/2021 | Series A | $14M | 11/2021 | Grant | 1 | $2.9M |
Horizon Capital Horizon Capital |
10/2021 | Grant | $2.9M |
Horizon Europe |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|